Laura J Sommerville1, Sheri E Kelemen, Michael V Autieri. 1. Department of Physiology, Independence Blue Cross Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Abstract
OBJECTIVE: Allograft Inflammatory Factor-1 (AIF-1) is a calcium binding scaffold protein which is rapidly induced in vascular smooth muscle cells (VSMCs) in response to injury and inflammation. A transgenic mouse in which AIF-1 expression was driven by a VSMC-specific SM22alpha promoter was generated to establish a direct relationship between AIF-1 expression and intimal hyperplasia. METHODS AND RESULTS: Morphological analysis of partially ligated carotid artery demonstrate a significant increase in neointimal area of AIF-1 Tg versus wild-type mice (569+/-64 um versus 256+/-49 um, P=0.004). Immunohistochemistry using antibody to the proliferation marker Ki-67 show a significantly greater number of proliferating cells in the AIF-1 Tg lesion compared with wild-type arteries (10.6%+/-1.0 versus 3.6%+/-.9, P=0.0007). AIF-1 Tg arteries also had a greater number of cells with activated signal transduction kinase p38 (55.4%+/-7.0 versus 22.6%+/-5.4, P=0.002) and PAK1 (67.5%+/-6.7 versus 35.3%+/-10.2, P=0.02) compared with wild-type. Cultured VSMCs explanted from AIF-1 Tg proliferate (55.5+/-3.6x10(3) versus 37.2+/-2.0x10(3) cells/mL, P=0.0001) and migrate more rapidly (39.2+/-3.2 versus 17.1+/-1.5 VSMCs per HPF, P=0.0003) than wild-type, and have significantly greater levels of activated p38 and PAK1 than did VSMCs from wild-type littermates (P<0.05). CONCLUSIONS: These data indicate that AIF-1 expression results in increased signal transduction, neointimal formation, and VSMC proliferation in injured mouse carotid arteries.
OBJECTIVE:Allograft Inflammatory Factor-1 (AIF-1) is a calcium binding scaffold protein which is rapidly induced in vascular smooth muscle cells (VSMCs) in response to injury and inflammation. A transgenicmouse in which AIF-1 expression was driven by a VSMC-specific SM22alpha promoter was generated to establish a direct relationship between AIF-1 expression and intimal hyperplasia. METHODS AND RESULTS: Morphological analysis of partially ligated carotid artery demonstrate a significant increase in neointimal area of AIF-1 Tg versus wild-type mice (569+/-64 um versus 256+/-49 um, P=0.004). Immunohistochemistry using antibody to the proliferation marker Ki-67 show a significantly greater number of proliferating cells in the AIF-1Tg lesion compared with wild-type arteries (10.6%+/-1.0 versus 3.6%+/-.9, P=0.0007). AIF-1 Tg arteries also had a greater number of cells with activated signal transduction kinase p38 (55.4%+/-7.0 versus 22.6%+/-5.4, P=0.002) and PAK1 (67.5%+/-6.7 versus 35.3%+/-10.2, P=0.02) compared with wild-type. Cultured VSMCs explanted from AIF-1 Tg proliferate (55.5+/-3.6x10(3) versus 37.2+/-2.0x10(3) cells/mL, P=0.0001) and migrate more rapidly (39.2+/-3.2 versus 17.1+/-1.5 VSMCs per HPF, P=0.0003) than wild-type, and have significantly greater levels of activated p38 and PAK1 than did VSMCs from wild-type littermates (P<0.05). CONCLUSIONS: These data indicate that AIF-1 expression results in increased signal transduction, neointimal formation, and VSMC proliferation in injured mouse carotid arteries.
Authors: F J Iris; L Bougueleret; S Prieur; D Caterina; G Primas; V Perrot; J Jurka; P Rodriguez-Tome; J M Claverie; J Dausset Journal: Nat Genet Date: 1993-02 Impact factor: 38.330
Authors: David S Weber; Yoshihiro Taniyama; Petra Rocic; Puvi N Seshiah; Melissa A Dechert; William T Gerthoffer; Kathy K Griendling Journal: Circ Res Date: 2004-04-01 Impact factor: 17.367
Authors: Michael V Autieri; Sheri Kelemen; Bernadette A Thomas; Erika D Feller; Bruce I Goldman; Howard J Eisen Journal: Circulation Date: 2002-10-22 Impact factor: 29.690
Authors: Lisa M Berglund; Olga Kotova; Peter Osmark; Helena Grufman; Chen Xing; Marie-Louise Lydrup; Isabel Goncalves; Michael V Autieri; Maria F Gomez Journal: Cardiovasc Res Date: 2011-11-23 Impact factor: 10.787
Authors: Laura J Sommerville; Sheri E Kelemen; Stephen P Ellison; Ross N England; Michael V Autieri Journal: Atherosclerosis Date: 2011-08-06 Impact factor: 5.162
Authors: Stephen Ellison; Khatuna Gabunia; James M Richards; Sheri E Kelemen; Ross N England; Dan Rudic; Yasu-Taka Azuma; M Alexandra Munroy; Satoru Eguchi; Michael V Autieri Journal: Am J Pathol Date: 2014-05-09 Impact factor: 4.307
Authors: Laura J Sommerville; Chen Xing; Sheri E Kelemen; Satoru Eguchi; Michael V Autieri Journal: Cardiovasc Res Date: 2008-09-08 Impact factor: 10.787
Authors: Anne H Rowley; Susan C Baker; Kwang-Youn A Kim; Stanford T Shulman; Amy Yang; David Arrollo; Matthew DeBerge; Shuling Han; Nicholas E S Sibinga; Adam J Pink; Edward B Thorp Journal: J Pediatric Infect Dis Soc Date: 2017-09-01 Impact factor: 3.164
Authors: Troels Thim; Mette Kallestrup Hagensen; Arne Hørlyck; Won Yong Kim; Anders K Niemann; Samuel Alberg Thrysøe; Ludovic Drouet; William P Paaske; Hans Erik Bøtker; Erling Falk Journal: J Cardiovasc Dis Res Date: 2012-04